Loading...

Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: a pilot placebo-controlled trial

OBJECTIVE: Obsessive-compulsive disorder (OCD) affects approximately 2.5% of the population and is associated with significant morbidity. Many patients receive little benefit from the best available treatments, and even those who do respond often suffer from significant residual symptoms. Convergent...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Clin Psychiatry
Main Authors: Pittenger, Christopher, Bloch, Michael H., Wasylink, Suzanne, Billingslea, Eileen, Simpson, Ryan, Jakubovski, Ewgeni, Kelmendi, Ben, Sanacora, Gerard, Coric, Vladimir
Format: Artigo
Sprog:Inglês
Udgivet: 2015
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4560666/
https://ncbi.nlm.nih.gov/pubmed/26214725
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4088/JCP.14m09123
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!